{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:24:46Z","timestamp":1792164286134,"version":"4.4.0"},"reference-count":53,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T00:00:00Z","timestamp":1149811200000},"content-version":"vor","delay-in-days":1196,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1080\/1355621031000069837","type":"journal-article","created":{"date-parts":[[2003,11,11]],"date-time":"2003-11-11T16:23:59Z","timestamp":1068567839000},"page":"13-21","source":"Crossref","is-referenced-by-count":23,"title":["Treatment of nicotine dependence with bupropion SR: review of its efficacy, safety and pharmacological profile"],"prefix":"10.1111","volume":"8","author":[{"given":"JOS\u00c9","family":"MART\u00cdNEZ-RAGA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FRANCIS","family":"KEANEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GAY","family":"SUTHERLAND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BARTOLOME","family":"PEREZ-GALVEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHN","family":"STRANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,6,9]]},"reference":[{"key":"10.1080\/1355621031000069837-BIB1|cit1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/archpsyc.58.9.810","article-title":"Nicotine dependence in the United States. Prevalence, trends, and smoking persistence","volume":"58","author":"Breslau","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1080\/1355621031000069837-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0140-6736(92)91600-D","article-title":"Mortality from tobacco in developed countries: indirect estimation from national statistics","volume":"39","author":"Peto","year":"1992","journal-title":"Lancet"},{"key":"10.1080\/1355621031000069837-BIB3|cit3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1037\/0022-006X.61.5.743","article-title":"Nicotine delivery kinetics and abuse liability","volume":"61","author":"Henningfield","year":"1993","journal-title":"J Consult Clin Psychol"},{"key":"10.1080\/1355621031000069837-BIB4|cit4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/382255a0","article-title":"Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs","volume":"382","author":"Pontieri","year":"1996","journal-title":"Nature"},{"key":"10.1080\/1355621031000069837-BIB5|cit5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s002130100681","article-title":"The dorsal raph\u00e9 nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses","volume":"155","author":"Cheeta","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1080\/1355621031000069837-BIB6|cit6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0193-953X(05)70078-2","article-title":"Neurobiology of tobacco smoking and other addictive disorders","volume":"22","author":"Gamberino","year":"1999","journal-title":"Psychiatr Clin North Am"},{"key":"10.1080\/1355621031000069837-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1001\/jama.1992.03490190087036","article-title":"Tobacco dependence and the nicotine patch: Clinical guidelines on effective use","volume":"268","author":"Fiore","year":"1992","journal-title":"JAMA"},{"key":"10.1080\/1355621031000069837-BIB8|cit8","article-title":"Nicotine replacement therapy for smoking cessation","author":"Silagy","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1080\/1355621031000069837-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199710233371703","article-title":"A comparison of sustained released bupropion and placebo for smoking cessation","volume":"337","author":"Hurt","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1080\/1355621031000069837-BIB10|cit10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1080\/1355621031000069837-BIB11|cit11","first-page":"395","article-title":"Bupropion: a review of its mechanisms of antidepressant activity","volume":"56","author":"Ascher","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1080\/1355621031000069837-BIB12|cit12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/npp.1994.43","article-title":"Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism","volume":"11","author":"Cooper","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1080\/1355621031000069837-BIB13|cit13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s002130000665","article-title":"Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment","volume":"155","author":"Dong","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1080\/1355621031000069837-BIB14|cit14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s002130050022","article-title":"The effect of bupropion on nicotine craving and withdrawal","volume":"148","author":"Shiffman","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1080\/1355621031000069837-BIB15|cit15","first-page":"321","article-title":"Bupropion is a nicotinic antagonist","volume":"295","author":"Slemmer","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/1355621031000069837-BIB16|cit16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/clpt.1994.105","article-title":"Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone","volume":"56","author":"Rose","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1080\/1355621031000069837-BIB17|cit17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/j.1552-4604.1997.tb04361.x","article-title":"Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers","volume":"37","author":"Hsyu","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"10.1080\/1355621031000069837-BIB18|cit18","volume-title":"Wellcome Bupropion hydrochloride (Zyban\u2122) sustained release prescribing information Research Triangle Park","author":"Glaxo","year":"May 2001"},{"key":"10.1080\/1355621031000069837-BIB19|cit19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/106002809302700406","article-title":"Excretion of bupropion in breast milk","volume":"27","author":"Briggs","year":"1993","journal-title":"Ann Pharmacother"},{"key":"10.1080\/1355621031000069837-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2165\/00003495-200059040-00019","article-title":"Bupropion: a review of its use in the management of smoking cessation","volume":"59","author":"Holm","year":"2000","journal-title":"Drugs"},{"key":"10.1080\/1355621031000069837-BIB21|cit21","first-page":"1176","article-title":"CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants","volume":"28","author":"Hesse","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1080\/1355621031000069837-BIB22|cit22","first-page":"79","volume":"44","author":"Schroeder DH Metabolism and kinetics of bupropion","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"10.1080\/1355621031000069837-BIB23|cit23","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/j.1552-4604.1995.tb04132.x","article-title":"Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression","volume":"35","author":"Sweet","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1080\/1355621031000069837-BIB24|cit24","first-page":"328","article-title":"Disposition of bupropion in healthy volunteers and subjects with alcoholic liver disease","volume":"10","author":"Vane","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"10.1080\/1355621031000069837-BIB25|cit25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00004714-199510000-00004","article-title":"Carbamazepine but not valproate induces bupropion metabolism","volume":"15","author":"Ketter","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"10.1080\/1355621031000069837-BIB26|cit26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/10401239509149035","article-title":"Bupropion and anticonvulsant drug interactions","volume":"7","author":"Popli","year":"1995","journal-title":"Ann Clin Psychiatry"},{"key":"10.1080\/1355621031000069837-BIB27|cit27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/j.1875-9114.1998.tb03830.x","article-title":"Update: clinically significant cytochrome P-450 drug interactions","volume":"18","author":"Michalets","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1080\/1355621031000069837-BIB28|cit28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00007691-199610000-00010","article-title":"Bupropion plasma levels and CYP2D6 phenotype","volume":"18","author":"Pollock","year":"1996","journal-title":"Ther Drug Monit"},{"key":"10.1080\/1355621031000069837-BIB29|cit29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00004714-199704000-00011","article-title":"A possible bupropion and imipramine interaction","volume":"17","author":"Shad","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1080\/1355621031000069837-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1592\/phco.20.19.1448.34866","article-title":"Effects of steady-state bupropion on the pharmacokinetics of lamotrigine in healthy subjects","volume":"20","author":"Odishaw","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1080\/1355621031000069837-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1177\/009127009903901111","article-title":"Lack of effect of cimetidine on the pharmacokinetics of sustained-release bupropion","volume":"39","author":"Kustra","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1080\/1355621031000069837-BIB32|cit32","volume-title":"Clinical practice guideline","author":"Fiore","year":"2000"},{"key":"10.1080\/1355621031000069837-BIB33|cit33","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/thorax.55.12.987","article-title":"Smoking cessation guidelines for health professionals: an update","volume":"55","author":"West","year":"2000","journal-title":"Thorax"},{"key":"10.1080\/1355621031000069837-BIB34|cit34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4088\/JCP.v59n0705","article-title":"A prospective safety surveillance study for bupropion sustained-release in the treatment of depression","volume":"59","author":"Dunner","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1080\/1355621031000069837-BIB35|cit35","first-page":"262","article-title":"Treatment of bulimia with bupropion: a multicenter controlled trial","volume":"49","author":"Horne","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"10.1080\/1355621031000069837-BIB36|cit36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1192\/bjp.174.2.173","article-title":"Effectiveness of bupropion for smoking cessation in smokers with a former history of major depression and alcoholism","volume":"174","author":"Hayford","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1080\/1355621031000069837-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1378\/chest.119.5.1357","article-title":"Bupropion for smoking cessation","volume":"119","author":"Dale","year":"2001","journal-title":"Chest"},{"key":"10.1080\/1355621031000069837-BIB38|cit38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14622200110042852","article-title":"Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation","volume":"3","author":"Johnston","year":"2001","journal-title":"Nicotine Tob Res"},{"key":"10.1080\/1355621031000069837-BIB39|cit39","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0149-2918(01)80023-0","article-title":"Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo","volume":"23","author":"Jamerson","year":"2001","journal-title":"Clin Ther"},{"key":"10.1080\/1355621031000069837-BIB40|cit40","first-page":"20","volume-title":"Bupropion SR (Zyban?) is an effective and well-tolerated aid to smoking cessation: an international study (zyb40017) [poster]","author":"Tonstad","year":"September 2001"},{"key":"10.1080\/1355621031000069837-BIB41|cit41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.7326\/0003-4819-135-6-200109180-00011","article-title":"Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. A randomized controlled trial","volume":"135","author":"Hays","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1080\/1355621031000069837-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0140-6736(00)04724-3","article-title":"Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial","volume":"357","author":"Tashkin","year":"2001","journal-title":"Lancet"},{"key":"10.1080\/1355621031000069837-BIB43|cit43","first-page":"20","volume-title":"Bupropion SR (Zyban?) is an effective and well-tolerated aid to smoking cessation in smokers with cardiovascular disease: an international study [poster]","author":"McRobbie","year":"September 2001"},{"key":"10.1080\/1355621031000069837-BIB44|cit44","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1345\/aph.19297","article-title":"Bupropion-induced serum sickness-like reaction","volume":"34","author":"McCollom","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1080\/1355621031000069837-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/jama.282.19.1817","article-title":"Serum sickness-like reaction with bupropion","volume":"282","author":"Peloso","year":"1999","journal-title":"JAMA"},{"key":"10.1080\/1355621031000069837-BIB46|cit46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00004714-199904000-00017","article-title":"Rhabdomyolysis associated with bupropion treatment","volume":"19","author":"David","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1080\/1355621031000069837-BIB47|cit47","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4088\/JCP.v58n0507a","article-title":"Reversible dyskinesia during bupropion therapy","volume":"58","author":"Gardos","year":"1997","journal-title":"J Clin Psychiat"},{"key":"10.1080\/1355621031000069837-BIB48|cit48","first-page":"644","article-title":"Bupropion-SR-induced increased libido and spontaneous orgasm","volume":"43","author":"Labbate","year":"1998","journal-title":"Can J Psychiat"},{"key":"10.1080\/1355621031000069837-BIB49|cit49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0735-6757(94)90195-3","article-title":"Bupropion overdose: a 3-year multi-centre retrospective analysis","volume":"12","author":"Spiller","year":"1994","journal-title":"Am J Emergency Med"},{"key":"10.1080\/1355621031000069837-BIB50|cit50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1742-1241.2001.tb11017.x","article-title":"Bupropion overdose: a potential problem with the new \u2018miracle\u2019 anti-smoking drug","volume":"55","author":"Bhattacharjee","year":"2001","journal-title":"Int J Clin Pract"},{"key":"10.1080\/1355621031000069837-BIB51|cit51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/15563659709001220","article-title":"Fatal bupropion overdose","volume":"35","author":"Harris","year":"1997","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1080\/1355621031000069837-BIB52|cit52","volume-title":"Excellence Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation","author":"National Institute for Clinical","year":"March 2002"},{"key":"10.1080\/1355621031000069837-BIB53|cit53","article-title":"Anxiolytics and antidepressants for smoking cessation (Cochrane Review","volume":"2","author":"Hughes","year":"2000","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F1355621031000069837","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1080\/1355621031000069837\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T09:57:05Z","timestamp":1704967025000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1080\/1355621031000069837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,3]]}},"URL":"https:\/\/doi.org\/10.1080\/1355621031000069837","archive":["Portico"],"relation":{},"ISSN":["1355-6215"],"issn-type":[{"value":"1355-6215","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}